HR 124 · 119th CongressIn Committeecongress.gov ↗

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

What this bill does

AI plain-language summary

This bill would let states get federal money through Medicaid to help pay for teaching people with sickle cell disease about renal medullary carcinoma. The federal government would pay for half of what states spend on this education. Renal medullary carcinoma is a rare kidney disease that usually happens in people with the sickle cell trait.

Introduced

January 3, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.